Clinical trial
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low…
NCT00323804 · ANRS, Emerging Infectious Diseases, Other · Completed
Key facts
| NCT number | NCT00323804 |
|---|---|
| Title | Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy. |
| Official title | Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating the Interest of a Long-term (3 Years) Treatment With Peginterferon Alfa-2b and Ribavirin on Liver Fibrosis in Non-responder Chronic Hepatitis C Patients. |
| Lead sponsor | ANRS, Emerging Infectious Diseases, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry Rennes University Hospital |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic, Liver Fibrosis |
| Intervention type | Biological, Drug |
| Interventions | Peginterferon alfa-2b, Ribavirin, Ribavirin-Placebo |
| Enrollment | 372 |
| Start date | May 1, 2006 |
| Primary completion | Feb 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | May 10, 2006 |
| Last update posted | Sep 4, 2014 |
| Countries | Belgium, France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: